Cargando…

Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis

Osteoporosis, characterized by the destruction of bone resorption and bone formation, is a serious disease that endangers human health. Osteoporosis prevention and treatment has become one of the important research contents in the field of medicine. Acacetin, a natural flavonoid compound, could prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiao, Xu, Fang, Zhang, Ke-Wen, Qiu, Wu-Xia, Zhang, Hui, Hao, Qiang, Li, Meng, Deng, Xiao-Ni, Tian, Ye, Chen, Zhi-Hao, Qian, Ai-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062130/
https://www.ncbi.nlm.nih.gov/pubmed/35517504
http://dx.doi.org/10.3389/fcell.2022.796227
_version_ 1784698865581031424
author Lin, Xiao
Xu, Fang
Zhang, Ke-Wen
Qiu, Wu-Xia
Zhang, Hui
Hao, Qiang
Li, Meng
Deng, Xiao-Ni
Tian, Ye
Chen, Zhi-Hao
Qian, Ai-Rong
author_facet Lin, Xiao
Xu, Fang
Zhang, Ke-Wen
Qiu, Wu-Xia
Zhang, Hui
Hao, Qiang
Li, Meng
Deng, Xiao-Ni
Tian, Ye
Chen, Zhi-Hao
Qian, Ai-Rong
author_sort Lin, Xiao
collection PubMed
description Osteoporosis, characterized by the destruction of bone resorption and bone formation, is a serious disease that endangers human health. Osteoporosis prevention and treatment has become one of the important research contents in the field of medicine. Acacetin, a natural flavonoid compound, could promote osteoblast differentiation, and inhibit osteoclast formation in vitro. However, the mechanisms of acacetin on osteoclast differentiation and type H vessel formation, as well as the effect of preventing bone loss, remain unclear. Here, we firstly used primary bone marrow derived macrophages (BMMs), endothelial progenitor cells (EPCs), and ovariectomized (OVX) mice to explore the function of acacetin on bone remodeling and H type vessel formation. In this study, we found that acacetin inhibits osteoclast formation and bone resorption of BMMs induced by the macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL) in a concentration of 20 μM without exerting cytotoxic effects. It was accompanied by downregulation of osteoclast differentiation marker genes (Ctsk, Acp5, and Mmp9) and cell fusion genes (CD9, CD47, Atp6v0d2, Dc-stamp, and Oc-stamp). Moreover, acacetin disrupted actin ring formation and extracellular acidification in osteoclasts. Mechanistic analysis revealed that acacetin not only inhibits the expression of the major transcription factor NFATc1 and NF-κB during RANKL-induced osteoclast formation, but also suppresses RANKL-induced the phosphorylation of Akt, GSK3β, IκBα, and p65. Additionally, acacetin enhanced the ability of M-CSF and RANKL-stimulated BMMs to promote angiogenesis and migration of EPCs. We further established that, in vivo, acacetin increased trabecular bone mass, decreased the number of osteoclasts, and showed more type H vessels in OVX mice. These data demonstrate that acacetin prevents OVX-induced bone loss in mice through inhibition of osteoclast function and promotion of type H vessel formation via Akt/GSK3β and NF-κB signalling pathway, suggesting that acacetin may be a novel therapeutic agent for the treatment of osteoporosis.
format Online
Article
Text
id pubmed-9062130
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90621302022-05-04 Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis Lin, Xiao Xu, Fang Zhang, Ke-Wen Qiu, Wu-Xia Zhang, Hui Hao, Qiang Li, Meng Deng, Xiao-Ni Tian, Ye Chen, Zhi-Hao Qian, Ai-Rong Front Cell Dev Biol Cell and Developmental Biology Osteoporosis, characterized by the destruction of bone resorption and bone formation, is a serious disease that endangers human health. Osteoporosis prevention and treatment has become one of the important research contents in the field of medicine. Acacetin, a natural flavonoid compound, could promote osteoblast differentiation, and inhibit osteoclast formation in vitro. However, the mechanisms of acacetin on osteoclast differentiation and type H vessel formation, as well as the effect of preventing bone loss, remain unclear. Here, we firstly used primary bone marrow derived macrophages (BMMs), endothelial progenitor cells (EPCs), and ovariectomized (OVX) mice to explore the function of acacetin on bone remodeling and H type vessel formation. In this study, we found that acacetin inhibits osteoclast formation and bone resorption of BMMs induced by the macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL) in a concentration of 20 μM without exerting cytotoxic effects. It was accompanied by downregulation of osteoclast differentiation marker genes (Ctsk, Acp5, and Mmp9) and cell fusion genes (CD9, CD47, Atp6v0d2, Dc-stamp, and Oc-stamp). Moreover, acacetin disrupted actin ring formation and extracellular acidification in osteoclasts. Mechanistic analysis revealed that acacetin not only inhibits the expression of the major transcription factor NFATc1 and NF-κB during RANKL-induced osteoclast formation, but also suppresses RANKL-induced the phosphorylation of Akt, GSK3β, IκBα, and p65. Additionally, acacetin enhanced the ability of M-CSF and RANKL-stimulated BMMs to promote angiogenesis and migration of EPCs. We further established that, in vivo, acacetin increased trabecular bone mass, decreased the number of osteoclasts, and showed more type H vessels in OVX mice. These data demonstrate that acacetin prevents OVX-induced bone loss in mice through inhibition of osteoclast function and promotion of type H vessel formation via Akt/GSK3β and NF-κB signalling pathway, suggesting that acacetin may be a novel therapeutic agent for the treatment of osteoporosis. Frontiers Media S.A. 2022-04-19 /pmc/articles/PMC9062130/ /pubmed/35517504 http://dx.doi.org/10.3389/fcell.2022.796227 Text en Copyright © 2022 Lin, Xu, Zhang, Qiu, Zhang, Hao, Li, Deng, Tian, Chen and Qian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Lin, Xiao
Xu, Fang
Zhang, Ke-Wen
Qiu, Wu-Xia
Zhang, Hui
Hao, Qiang
Li, Meng
Deng, Xiao-Ni
Tian, Ye
Chen, Zhi-Hao
Qian, Ai-Rong
Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
title Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
title_full Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
title_fullStr Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
title_full_unstemmed Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
title_short Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
title_sort acacetin prevents bone loss by disrupting osteoclast formation and promoting type h vessel formation in ovariectomy-induced osteoporosis
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062130/
https://www.ncbi.nlm.nih.gov/pubmed/35517504
http://dx.doi.org/10.3389/fcell.2022.796227
work_keys_str_mv AT linxiao acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT xufang acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT zhangkewen acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT qiuwuxia acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT zhanghui acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT haoqiang acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT limeng acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT dengxiaoni acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT tianye acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT chenzhihao acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis
AT qianairong acacetinpreventsbonelossbydisruptingosteoclastformationandpromotingtypehvesselformationinovariectomyinducedosteoporosis